Cited 19 times in
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 구철룡 | - |
dc.date.accessioned | 2022-02-23T01:17:04Z | - |
dc.date.available | 2022-02-23T01:17:04Z | - |
dc.date.issued | 2021-08 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/187617 | - |
dc.description.abstract | Since the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most countries, both mRNA and DNA vaccines have been administered, and their side effects have also been reported. The clinical course of COVID-19 and the effects of vaccination against COVID-19 are both influenced by patients' health status and involve a systemic physiological response. In view of the systemic function of endocrine hormones, endocrine disorders themselves and the therapeutics used to treat them can influence the outcomes of vaccination for COVID-19. However, there are very limited data to support the development of clinical guidelines for patients with specific medical backgrounds based on large clinical trials. In the current severe circumstances of the COVID-19 pandemic, position statements made by clinical specialists are essential to provide appropriate recommendations based on both medical evidence and clinical experiences. As endocrinologists, we would like to present the medical background of COVID-19 vaccination, as well as precautions to prevent the side effects of COVID-19 vaccination in patients with specific endocrine disorders, including adrenal insufficiency, diabetes mellitus, osteoporosis, autoimmune thyroid disease, hypogonadism, and pituitary disorders. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Endocrine Society | - |
dc.relation.isPartOf | Endocrinology and Metabolism(대한내분비학회지) | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | COVID-19 / epidemiology | - |
dc.subject.MESH | COVID-19 / immunology | - |
dc.subject.MESH | COVID-19 / prevention & control* | - |
dc.subject.MESH | COVID-19 Vaccines / administration & dosage | - |
dc.subject.MESH | COVID-19 Vaccines / adverse effects | - |
dc.subject.MESH | COVID-19 Vaccines / standards* | - |
dc.subject.MESH | Endocrine System Diseases* / epidemiology | - |
dc.subject.MESH | Endocrine System Diseases* / immunology | - |
dc.subject.MESH | Endocrinologists / standards* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Practice Guidelines as Topic / standards | - |
dc.subject.MESH | Republic of Korea / epidemiology | - |
dc.subject.MESH | Societies, Medical / standards* | - |
dc.subject.MESH | Vaccination / standards* | - |
dc.title | COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Cheol Ryong Ku | - |
dc.contributor.googleauthor | Kyong Yeun Jung | - |
dc.contributor.googleauthor | Chang Ho Ahn | - |
dc.contributor.googleauthor | Jun Sung Moon | - |
dc.contributor.googleauthor | Ju Hee Lee | - |
dc.contributor.googleauthor | Eun Heui Kim | - |
dc.contributor.googleauthor | Hyemi Kwon | - |
dc.contributor.googleauthor | Hee Kyung Kim | - |
dc.contributor.googleauthor | Sunghwan Suh | - |
dc.contributor.googleauthor | Sangmo Hong | - |
dc.contributor.googleauthor | Jeonghoon Ha | - |
dc.contributor.googleauthor | Eun Roh | - |
dc.contributor.googleauthor | Jin Hwa Kim | - |
dc.contributor.googleauthor | Mi-Kyung Kim | - |
dc.identifier.doi | 10.3803/EnM.2021.404 | - |
dc.contributor.localId | A00201 | - |
dc.relation.journalcode | J00773 | - |
dc.identifier.eissn | 2093-5978 | - |
dc.identifier.pmid | 34399446 | - |
dc.subject.keyword | Adrenal insufficiency | - |
dc.subject.keyword | COVID-19 vaccines | - |
dc.subject.keyword | Diabetes mellitus | - |
dc.subject.keyword | Hypogonadism | - |
dc.subject.keyword | Hypopituitarism | - |
dc.subject.keyword | Osteoporosis | - |
dc.subject.keyword | Pituitary neoplasms | - |
dc.subject.keyword | Thyroiditis, autoimmune | - |
dc.contributor.alternativeName | Ku, Cheol Ryong | - |
dc.contributor.affiliatedAuthor | 구철룡 | - |
dc.citation.volume | 36 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 757 | - |
dc.citation.endPage | 765 | - |
dc.identifier.bibliographicCitation | Endocrinology and Metabolism (대한내분비학회지), Vol.36(4) : 757-765, 2021-08 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.